Montserrat Plana

Grup de recerca

Sida i infecció per VIH Accredited researcher (R3A)

mplana@recerca.clinic.cat 0000-0002-0767-4329

Publicacions destacades

Use of RT-defective HIV virions: new tool to evaluate specific response in infected individuals

Autors:
Guardo, Alberto Crespo; Alvarez-Fernandez, Carmen; Arberas, Hodei; Garcia-Perez, Javier; Garcia, Felipe;

(...)

Gatell, Jose Maria; Mothe, Beatriz; Alcami, Jose; Sanchez-Palomino, Sonsoles; Plana, Montserrat.

Referència: Plos One 2013.
In vitro effects of the CCR5 inhibitor maraviroc on human T cell function

Autors:
Arberas, H; Guardo, A C; Bargallo, M E; Maleno, M J; Calvo, M;

Blanco, J L; Garcia, F; Gatell, J M; Plana, M.

Referència: Journal Of Antimicrobial Chemotherapy 2013.
A dendritic cell-based vaccine elicits T cell responses associated with control 1 replication

Autors:
Garcia, Felipe; Climent, Nuria; Guardo, Alberto C; Gil, Cristina; Leon, Agathe;

(...)

Dalmau, Judit; Clotet, Bonaventura; Gatell, Josep M; Plana, Montserrat; Gallart, Teresa.

Referència: Science Translational Medicine 2013.
Therapeutic vaccines against HIV infection

Autors:
Garcia, Felipe; Leon, Agathe; Gatell, Josep M; Plana, Montserrat; Gallart, Teresa;

Referència: Human Vaccines & Immunotherapeutics 2012.
Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine

Autors:
Lopez, Anna; Van Der Lubbe, Nils; Sanchez-Palomino, Sonsoles; Arnedo, Mireia; Nomdedeu, Meritxell;

(...)

Maleno, Maria J; Garcia, Felipe; Gallart, Teresa; Gatell, Jose M; Plana, Montserrat.

Referència: Vaccine 2009.
Short Communication: Natural killer cells and expression of KIR receptors in chronic HIV type 1-infected patients after different strategies of structured therapy interruption

Autors:
Peña Sanchez de Rivera, Jose Maria; Mestre, Gabriel; Garcia, Felipe; Martinez, Esteban; Milinkovic, Ana;

(...)

Argelich, Roger; Lozano, Jose Manuel; Pena, Jose; Gatell, Jose M; Plana, Montserrat.

Referència: Aids Research And Human Retroviruses 2008.
Redistribution of FOXP3-Positive regulatory T cells from lymphoid tissues to peripheral blood in HIV-Infected patients

Autors:
Mozos, Ana; Garrido, Marta; Carreras, Doaquim; Carreras, Joaquim; Plana, Montse;

Diaz, Alba; Alos, Llucia; Campo, Elias; Garcia, Felipe; Martinez, Antonio.

Referència: Jaids-Journal Of Acquired Immune Deficiency Syndromes 2007.
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3

Autors:
Plana, Montserrat; Garcia, Felipe; Oxenius, Annette; Ortiz, Gabriel M; Lopez, Anna;

(...)

Hirschel, Bernard; Phillips, Rodney E; Nixon, Douglas F; Gallart, Teresa; Gatell, Jose M.

Referència: Jaids-Journal Of Acquired Immune Deficiency Syndromes 2004.
Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3''A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression

Autors:
Soriano, A; Martínez, C; García, F; Plana, M; Palou, E;

(...)

Lorenzo, JI; Alcamí, J; del Romero, J; Miró, JM; Gallart, T.

Referència: Journal Of Infectious Diseases 2002.
Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors

Autors:
Plana, M; Martinez, C; Martinez, Catalina; Garcia, F; Garcia, Felipe;

(...)

Miro, Jose M; Pumarola, T; Gallart, T; Gallart, Teresa; Gatell, JM.

Referència: Jaids-Journal Of Acquired Immune Deficiency Syndromes 2002.

Projectes destacats

Red Temática de Investigación Cooperativa en Salud - SIDA (RIS)

Investigador/a principal: Felipe García

Finançador: Instituto de Salud Carlos III

Codi: RD16/0025/0002

Durada: 01/01/2017 - 31/12/2022
Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection (HIVACAR)

Investigador/a principal: Felipe García

Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) (Sede o evento); European Comission. CE_H2020-SC1_16abr1s

Codi: CE_H2020-SC1_16abr1s

Durada: 02/01/2017 - 31/12/2021
FluNanoAir Design of Human Influenza vaccines using multifunctional micelles harnessing innate immunity

Investigador/a principal: Montserrat Plana IP from Partner 2 (FCRB / IDIBAPS)

Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); EuroNanoMed II JTC 2016

Durada: 01/01/2017 - 31/12/2019
European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

Investigador/a principal: Felipe Garcia Alcaide, Giuseppe Pantaleo Co-IP

Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) incluyendo 39 partners (Sede o evento); European Comunity's (H2020) Grant agreement n° 681032 ; European Comission

Codi: CE_H2020-PHCRTD-15

Durada: 02/01/2016 - 31/12/2020
DESARROLLO DE UNA VACUNA TERAPÉUTICA FRENTE AL VIH BASADA EN UNA NUEVA FORMULACIÓN DE mRNA CON NANOPARTÍCULAS

Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); FIS (Fondo de investigación Sanitaria; ISCIII) FIS PI15/00480

Durada: 01/01/2016 - 01/01/2018

Montserrat Plana

Grup de recerca

Publicacions destacades

Projectes destacats

Red Temática de Investigación Cooperativa en Salud - SIDA (RIS)

Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection (HIVACAR)

FluNanoAir Design of Human Influenza vaccines using multifunctional micelles harnessing innate immunity

European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

DESARROLLO DE UNA VACUNA TERAPÉUTICA FRENTE AL VIH BASADA EN UNA NUEVA FORMULACIÓN DE mRNA CON NANOPARTÍCULAS

Subscriu-te a la Newsletter del Clínic